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Introduction
============

Signal transduction pathways, linking extracellular stimuli to intracellular processes, are essential for regulation of all cells. Their effective operation requires complex spatial and temporal organization that couples the component steps together. Phosphorylation--dephosphorylation pathways, for example, represent major cell control mechanisms, and generally the effector kinases and phosphatases and their protein targets are discretely compartmentalized in cells ([@bib40]; [@bib3]). Myosin II activity, for example in smooth muscle and nonmuscle cells, is regulated by phosphorylation, and the kinase responsible is anchored on actin filaments.

Myosin regulatory light chains are phosphorylated by Ca^2+^--calmodulin-dependent myosin light chain kinase (MLCK)[\*](#fn1){ref-type="fn"} and dephosphorylated by a distinct form of phosphatase type 1 (for reviews see [@bib16], [@bib17]; [@bib41]; [@bib7]; [@bib46]). There is no troponin in smooth muscle, and here, as in nonmuscle cells, Ca^2+^ binds to its target protein, calmodulin, as cytoplasmic Ca^2+^ concentration increases after cell stimulation. The Ca^2+^--calmodulin complex then binds to MLCK, leading to its activation, light chain phosphorylation, increased actin-activated myosin ATPase activity, cross-bridge cycling on thin filaments, and contraction. Both MLCK and phosphatase are modulated by phosphorylation and dephosphorylation, reactions mediated by signaling networks ([@bib48], [@bib49]; [@bib46]; [@bib26]).

There are two genes that express a skeletal muscle specific MLCK and a smooth muscle MLCK, respectively. The smooth muscle MLCK is ubiquitously expressed ([@bib12]) and consists of short and long isoforms due to multiple promoters in the gene ([@bib17]). Short MLCK is present in smooth muscle cells at ∼4 μM ([@bib11]; [@bib51]) in an approximate molar ratio to myosin of 1:10 and to actin in filaments of 1:100. The short MLCK isoform found in smooth muscle and some nonmuscle cells possesses an NH~2~-terminal actin-binding extension ([@bib18]; [@bib9]; [@bib60]), not present in skeletal muscle MLCK ([@bib37]; [@bib23]), that localizes the kinase to thin filaments, restricting its cellular mobility ([@bib10]; [@bib4]; [@bib42]). The long MLCK is the same as the short MLCK with additional actin-binding motifs and structural modules at the NH~2~ terminus. The long MLCK has a greater affinity for F-actin and is found primarily in nonmuscle cells ([@bib17]), where myosin II--based motility is also regulated by light chain phosphorylation. The resulting compartmentalization of MLCK may be involved in defining contractile regions in both smooth muscle and nonmuscle cells.

The NH~2~-terminal extensions contain a novel high-affinity actin-binding sequence, DFRXXL, which repeats three times in short MLCK, leading to binding saturation of one MLCK to three actin monomers along F-actin in vitro ([@bib45]; [@bib44]). Mutating the binding motifs significantly decreases association of MLCK with myofilaments in vitro and with actin-containing filaments in intact smooth muscle cells ([@bib45]). The full-length short kinase is an elongated molecule, and intervening PEVK, Ig-like, and fibronectin-like repeats between NH~2~-terminal and more COOH-terminal catalytic domains are thought to provide sufficient extension for the catalytic core to reach thick filaments abutting thin filaments ([@bib48]; [@bib24]; [@bib44]), thus allowing effective light chain phosphorylation of cross-bridges. A COOH-terminal low-affinity myosin-binding fragment in MLCK ([@bib42]) may direct the kinase towards myosin filaments, increasing the probability of myosin phosphorylation during activity, whereas the NH~2~ terminus binds with sufficient high affinity to anchor the kinase to actin filaments. Additionally, since MLCK apparently is not dissociated from thin filaments by Ca^2+^ or Ca^2+^--calmodulin ([@bib24]), the enzyme will localize close to thin and thick filaments both at the onset and during contractile activity.

Actin, the core of the thin filament, serves as a molecular track for the myosin cross-bridge motor. Tropomyosin, also present on thin filaments, ensures that on--off switching of myosin ATPase and consequently contractility occurs cooperatively, narrowing the Ca^2+^ concentration range required for regulation ([@bib22]). Smooth muscle and nonmuscle thin filaments also contain the protein caldesmon and smooth muscle filaments calponin, both often implicated in the regulation of thin filaments but of uncertain function despite extensive biochemical characterization ([@bib28]; [@bib2]; [@bib29]; [@bib58]). Structural information on the interactions of each of these proteins with F-actin has been extracted from three-dimensional (3-D) reconstructions ([@bib54]; [@bib57]; [@bib13],[@bib14]; [@bib21]; [@bib56]). Together, these proteins and myosin cover and/or move over much of the outer face of actin, leaving little room free for extra binding proteins, hence raising the possibility of a structural competition and functional clash with actin-bound MLCK. In the current report, the interactions of MLCK on F-actin were examined structurally. The site of MLCK binding was determined by electron microscopy and 3-D reconstruction to assess if MLCK is specifically and uniquely localized on F-actin. We found that MLCK associates between laterally adjacent actin monomers on F-actin, over an unoccupied patch far from the myosin-binding site and from sites occupied by tropomyosin, caldesmon, and calponin on actin. Hence, MLCK binding should not interfere sterically with myosin cross-bridge cycling, cooperative activation by tropomyosin, or the operation of caldesmon or calponin.

Results and discussion
======================

Electron microscopy of F-actin--MLCK-147 complexes
--------------------------------------------------

F-actin was complexed with peptide containing the NH~2~-terminal 147 residues of MLCK (MLCK-147) under conditions that should saturate filaments with the protein. Electron micrographs of negatively stained filaments showed that the MLCK peptide caused extensive cross-linking of F-actin into loosely packed bundles and rafts. Only unbundled filaments within aggregates or those splaying off laterally were analyzed. Actin substructure, although evident, was frequently obscured by the binding of the MLCK-147 on the surface of filaments ([Fig. 1](#fig1){ref-type="fig"}) , which also caused them to appear wider than pure F-actin. Globular structures were occasionally seen projecting from filaments but details of the shape, orientation, and periodicity of the MLCK peptide were not discernable. To detect the MLCK binding and determine its position on F-actin, image processing and 3-D reconstruction were therefore necessary.

![**Electron micrographs of negatively stained filaments.** (a) Rabbit skeletal muscle F-actin alone (two examples). (b) Skeletal muscle F-actin--MLCK-147 (five examples). Note the increased diameter of the decorated F-actin. Bar, 50 nm.](0105079f1){#fig1}

3-D reconstructions of reconstituted thin filaments
---------------------------------------------------

Electron micrographs of two different sets of F-actin--MLCK-147 were analyzed independently by the first and last authors. Density maps of reconstituted filaments were calculated from the averages of the Fourier transform layer line data (not shown). All maps obtained showed typical two-domain actin monomers that could be further divided into identifiable subdomains ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}) . When compared with maps generated from pure F-actin controls, each separately calculated reconstruction showed obvious extra density lying between the inner domain of one actin and the outer domain of the next monomer along the left-handed genetic helix of F-actin ([Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, arrows). Since the two data sets were so similar, they were combined for further analysis. The extra mass, attributable to the MLCK peptide, and its location became especially apparent when difference densities computed between maps of F-actin--MLCK-147 and F-actin were superimposed on the F-actin reconstructions (filled black region in [Figs. 2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, respectively). The computed difference densities were statistically significant at confidence levels \>99.95%. The statistical analysis confirmed that the only significant difference between the control and MLCK maps was the mass bridging successive monomers. Inspection of the surface views of reconstructions ([Fig. 3](#fig3){ref-type="fig"}) showed that part of the MLCK density is connected to a relatively broad part of the back of actin subdomain-1. The opposite side of MLCK approaches a protuberance on the bottom of subdomain-4 of the next actin monomer along the F-actin genetic helix (subdomains noted on four successive actin monomers). The MLCK density therefore appears to link respective monomers together.

![**Transverse sections (z-sections) of 3-D reconstructions.** (a) F-actin control. Because adjacent actin monomers are staggered by ∼1/2 × 55 Å, sectioning the reconstruction through the widest part of one actin (monomer on the right) results in sectioning through a narrower part of the adjacent one (on the left); outer and inner domains are marked A~o~ and A~i~ on each. (b) F-actin--MLCK-147; note the extra density (arrow) due to MLCK on the extreme periphery of the map bridging inner and outer domains of the two actin monomers sectioned. (c) Maps in a and b were compared, and the difference between the two (filled black region) was superimposed on a copy of the F-actin map. The difference densities, attributable to the bound MLCK, were statistically significant at *\>*99.95% confidence levels. This analysis also showed that the protein-free pore between the MLCK density and F-actin (\* in b; cross-hatching in c) was negatively significant, as if decorated filaments drew in extra stain in this region. Sections shown are at the same axial position and have the same relative orientation. The average phase residual (Ψ ± SD), a measurement of the geometrical agreement among filaments generating reconstructions, was 54.0 ± 5.9° for the F-actin--MLCK-147 data. The average up--down phase residual (ΔΨ ± SD), a measure of filament polarity, was 23.7 ± 8.5°. The two values were comparable to those previously obtained.](0105079f2){#fig2}

![**Surface views of thin filament reconstructions showing the position of the MLCK-147 peptide on F-actin.** (a) F-actin control; actin subdomains are noted on four of the successive actin monomers (subscripts distinguish the particular monomer labeled; monomers with odd-numbered subscripts present face-on views of actin, and ones with even-numbered subscripts show reverse-side views). (b) MLCK-147--decorated F-actin; note the extra mass (arrows) not present in control filaments that link the bottom of subdomain-4 of each actin monomer to the back of subdomain-1 of the adjacent one. (c) To further define the relative position of MLCK-147, difference densities (filled black region) were calculated as described above and then superimposed on the F-actin reconstruction. Again, note the position of the difference density bridging between neighboring monomers and then extending downward toward the barbed end of the filament. Connectivity was not noted between axially adjacent MLCK-147 densities, and therefore the results did not allow us to determine if the MLCK peptide is arranged longitudinally along F-actin as suggested by binding studies ([@bib44]). However, any possible linkage, predicted by [@bib44], between successive binding domains may have been too thin or too disordered to be detected by the methods applied.](0105079f3){#fig3}

Fitting MLCK on the atomic model of F-actin
-------------------------------------------

To further define the MLCK-147 binding site on F-actin, the MLCK difference densities were localized on the refined atomic model of F-actin ([@bib25]) by fitting the atomic model within the envelope formed by the actin component of our reconstructions (compare with [@bib55]). The fitting ([Fig. 4](#fig4){ref-type="fig"}) indicated that one side of MLCK-147 (red) attached to COOH-terminal residues on subdomain-1 of one actin monomer and that the opposite side of the peptide closely approached an α-helix (representing actin residues 228--232) protruding from subdomain-4 of the neighboring monomer. The MLCK binding site is distinct from consensus actin binding sites previously observed ([@bib30]).

![**Location of MLCK-147 densities on the atomic structure of F-actin.** The atomic model of F-actin ([@bib25]) was fitted to the EM reconstructions as previously described ([@bib55]), and the location of the MLCK difference density on the atomic model was established. Two neighboring actin monomers are displayed as α-carbon chains: one in green (face-on view of actin) and the other in yellow (reverse-side view; note that these two monomers correspond to actin monomers 1 and 2 in [Fig. 3](#fig3){ref-type="fig"}). The fitted MLCK density (red) approaches an α-helix projecting from actin subdomain-4 on one monomer (residues 228--232 highlighted in magenta) and comes into close contact with the COOH-terminal α-helix of actin subdomain-1 on the other (residues 364--375 highlighted in white). Without an atomic model of MLCK-147 available as a reference for molecular fitting, an exact description of the volume, shape, orientation, and contact points of the MLCK density on F-actin is precluded by the resolution and positional accuracy of the data.](0105079f4){#fig4}

Molecular model of MLCK--actin binding
--------------------------------------

Circular dichroism studies indicate that MLCK-147 is largely unstructured without α-helix and β-sheet content (unpublished data). Despite this, our observations here indicate that, once associated with F-actin, MLCK-147 assumed a fairly compact shape, as if a structured conformation was induced by binding to actin. Further inspection of the residues involved in the docking site of MLCK on actin revealed a stretch of charged and hydrophobic residues at the COOH-terminal region of F-actin complementary to those in the MLCK-147 binding motif, suggesting that binding might occur as illustrated in the model in [Fig. 5](#fig5){ref-type="fig"} , in which the DFRXXL residues of MLCK-147 associate with the Arg374, Val372, Glu366, and Tyr364 of actin, respectively.

![**Space-filling model of actin showing possible sites of interaction with the MLCK-binding motif.** The amino acid sequence and 3-D structure of chicken aortic actin were evaluated in light of both the molecular fitting depicted in [Fig. 4](#fig4){ref-type="fig"} and data on the DFRXXL binding motif. The space-filling model shows that the COOH-terminal actin residues Arg374 (green), Val372 (yellow), Glu366 (magenta), and Tyr364 (off-white) on the actin surface could make alternating electrostatic and hydrophobic interactions with DFRXXL (drawn schematically). If this were true, then the apparent binding to residues 228--232 of a laterally adjacent actin monomer (as in [Fig. 4](#fig4){ref-type="fig"}) would occur with flanking amino acids of the MLCK-147 construct.](0105079f5){#fig5}

Comparison of binding of MLCK and other actin-binding proteins
--------------------------------------------------------------

The amount of MLCK in smooth muscle and nonmuscle cells is substantially less than the amount of actin-binding sites ([@bib11]; [@bib50]), and it is therefore likely that MLCK will be targeted to actin filaments participating in myosin II--based motility (compare with [@bib35]; [@bib17]). These filaments contain several actin-binding proteins involved in regulating thin filament function that could potentially compete with MLCK for actin-binding sites. Since the locations of all major smooth muscle and key nonmuscle thin filament-associated proteins are known, their binding and that of MLCK could be compared structurally. Inspection of [Fig. 6](#fig6){ref-type="fig"} , a composite of difference density maps localizing the myosin binding site and positions of tropomyosin, caldesmon, calponin, and MLCK-147 on F-actin, demonstrates that the MLCK docking site is distinct from that of the others. The absence of any steric clash between the binding of MLCK and the other actin-binding proteins would favor the stability of the MLCK interaction. Moreover, the unique binding of MLCK would not interfere with myosin docking and cycling on actin. It is noteworthy that caldesmon and calponin densities do overlap structurally with each other ([Fig. 6](#fig6){ref-type="fig"}), consistent with significant binding competition of caldesmon and calponin observed in vitro and histological segregation in vivo ([@bib8]; [@bib43]; [@bib19]; [@bib27]; [@bib35],[@bib36]); in contrast, MLCK binding to native smooth muscle thin filaments is not blocked by the presence of tropomyosin, caldesmon, and/or calponin ([@bib45]). Together, studies on the structure of smooth muscle thin filaments demonstrate that actin-binding proteins adopt characteristic positions on the thin filament consistent with distinct functions. In the case of the short MLCK in smooth muscle, its NH~2~-terminal structural domain is anchored to a site where no other actin-binding protein to date has been localized (compare with [@bib30]). The long MLCK present in nonmuscle cells has two additional DFRXXL actin-binding motifs, and thus, it is predicted that its location will be similar except for a maximal stoichiometry of one long MLCK per five actin monomers in the thin filament. In both the short and long MLCKs, the intervening PEVK, Ig-like, and fibronectin modules would extend the catalytic core to myosin thick filaments, thereby allowing regulatory light chain phosphorylation upon activation by Ca^2+^--calmodulin. The design of the MLCK molecule is therefore well adapted for its part in the cascade of events leading to myosin II--based cellular motility.

![**Composite map displaying the relative positions of smooth muscle actin-binding proteins.** Binding locations of MLCK-147 (red), smooth muscle tropomyosin (TM, green; data from [@bib22]), calponin (CP, magenta; data from [@bib13]), and caldesmon (CD, yellow; derived from selected data in [@bib14]) were plotted on a transverse section of F-actin. The myosin-binding site on actin (from data of S-1--decorated thin filaments in [@bib33]; [@bib55]) is highlighted (MY, ochre). Note that the MLCK-binding site is far from each of the other actin-binding proteins.](0105079f6){#fig6}

Materials and methods
=====================

Protein preparation
-------------------

Construction and expression of MLCK-147: the cDNA fragment of the NH~2~-terminal 1--147 amino acids of rabbit smooth muscle MLCK was amplified by PCR and subcloned into TOPO cloning vector pCR 2.1 (Invitrogen). After sequencing, the cDNA was then subcloned into the expression vector pET 28a (Novagen) with a His-tag sequence at the NH~2~ terminus of MLCK-147. The expression constructs were transformed into bacteria strain BL21 (DE3), and protein expression was induced by IPTG. After centrifugation, the cells were resuspended in 20 mM Tris/HCl, pH 7.0, 1 mM EDTA, and 0.1% NP-40, sonicated, and centrifuged again. The soluble MLCK-147 peptide was purified by His-Bind Quick column as described by the manufacturer (Novagen). The purified MLCK-147 binds to F-actin with a *K* ~d~ value of 0.26 ± 0.01 μM and a stoichiometry of one MLCK-147 to three actin molecules. MLCK-147 contains the three DFRXXL motifs present in the 75--amino acid NH~2~-terminal fragment studied by [@bib44].

Rabbit skeletal muscle F-actin was purified by standard methods ([@bib47]). The F-actin used was stable and did not aggregate, an advantage for the structural studies performed. Different actin isoforms are highly conserved (we used skeletal muscle α-actin in our studies); isoform variability, in fact, occurs mainly at the acidic NH~2~-terminal six amino acids of actin ([@bib53]; [@bib20]) whose position is distal from the site of MLCK-147 binding (see Results and discussion). There were no significant differences in binding affinity of NH~2~-terminal MLCK fragments to skeletal muscle F-actin and detergent washed native smooth muscle myofilaments; the stoichiometry of binding was the same ([@bib44]; unpublished data).

Electron microscopy and helical reconstruction
----------------------------------------------

F-actin (1 μM) was decorated with excess MLCK-147 (2 μM) in solutions of 50 mM KCl, 1 mM EGTA, 1 mM MgCl~2~, 0.2 mM ATP, 1 mM DTT, 10 mM imidazole buffer (pH 7.2) at room temperature (∼25°C). Reconstituted filaments were immediately applied to carbon-coated electron microscope grids and negatively stained as previously described ([@bib34]). Prolonged decoration was avoided, since F-actin and MLCK-147 incubated together for as short as 5 min formed very large and unusable filament aggregates. Electron micrograph images of decorated filaments were recorded on a Philips CM120 electron microscope at 60,000× magnification under low-dose conditions (∼12e^−^/Å^2^). Micrographs were digitized using a ZEISS SCAI scanner at a pixel size corresponding to 0.7 nm in the filaments. Well-stained regions of filaments were selected and straightened as previously described ([@bib6]; [@bib13]). Helical reconstruction was carried out by standard methods ([@bib5]; [@bib1]; [@bib39]) as previously described ([@bib54], [@bib55]). Two independently analyzed sets of filaments totaling 28 filaments were chosen for averaging, based on their relative phase agreement. The reconstruction had a resolution ([@bib38]) of 2.5--3.0 nm; the positional accuracy of the method is ∼0.5 nm ([@bib33]). Difference density analysis to define MLCK position on actin was carried out as previously described ([@bib59]), and differences between maps were evaluated statistically using a Student\'s *t* test ([@bib32]; [@bib52]). Fitting of reconstructions to the atomic resolution structure of F-actin ([@bib25]) was carried out as previously described ([@bib31]; [@bib55]; [@bib59]) using the program O ([@bib15]).
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